Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christopher M.L. Coppin"'
Autor:
Ivo A. Olivotto, Ian H. Plenderleith, Christopher M.L. Coppin, Vivian E. Basco, Nhu D. Le, John J. Spinelli, Marilyn Paradis, Joseph Ragaz, Kenneth S. Wilson, Margaret A. Knowling, Stewart M. Jackson, Andrew J. Coldman
Publikováno v:
The New England journal of medicine. 337(14)
Radiotherapy after mastectomy to treat early breast cancer has been known since the 1940s to reduce rates of local relapse. However, the routine use of postoperative radiotherapy began to decline in the 1980s because it failed to improve overall surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b64b0e2aa6c0788f05cf1358ef456e7
https://pubmed.ncbi.nlm.nih.gov/12587570
https://pubmed.ncbi.nlm.nih.gov/12587570
Autor:
Joseph Ragaz, Chris Bajdik, Stewart M. Jackson, Ivo A. Olivotto, Kenneth S. Wilson, Christopher M.L. Coppin, Ann J. Worth, Karen A. Gelmon, Ian H. Plenderleith
Publikováno v:
The New England journal of medicine. 330(12)
We examined the effect of adjuvant systemic therapy on survival after breast cancer among the residents of the Canadian province of British Columbia. Data on survival were collected for all women in whom breast cancer was diagnosed in British Columbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d175d20ec6a10f2375196be4b77372b2
https://pubmed.ncbi.nlm.nih.gov/8028630
https://pubmed.ncbi.nlm.nih.gov/8028630
Publikováno v:
American journal of clinical oncology. 13(1)
Mitomycin was used as single-agent therapy in seven male patients with nonseminomatous germ-cell tumors resistant to platinum analogues. The toxicity was high, especially hematological and pulmonary, in this heavily pretreated group. Mitomycin was ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f109a31cb2f216aa11485f65abfdca79
https://pubmed.ncbi.nlm.nih.gov/2154922
https://pubmed.ncbi.nlm.nih.gov/2154922
Publikováno v:
Mathematical Biosciences. 92:97-113
Hryniuk has recently advanced the proposal that the dose intensity of a therapeutic regimen, defined as the ratio of cumulative drug dose to therapeutic period, is an important predictor of the therapeutic outcome. We discuss two simple models of che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54564453c2471bfbdd0dfedf356627db
https://doi.org/10.1016/0025-5564(88)90007-7
https://doi.org/10.1016/0025-5564(88)90007-7